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Introduction
Up till now, altered balance of Th1 and Th2 immune
cells has been postulated to play an important role in
the pathogenesis of autoimmune thyroid diseases
(AITD). However, recent studies on thyroid diseases
suggest a new role for Th17 (T helper 17) cells that
have been classified as a new lineage, distinct from Th1,
Th2 and Treg cells. Despite wide interest, the role of
Th17 cells in the pathogenesis of inflammatory and
autoimmune diseases is still being debated. Th17 cells
are involved in immune responses against extracellular
pathogens and have the ability to secrete cytokines:
IL-17, IL-17F, IL-21 and IL-23. Th17 cells can be char-
acterized by several surface markers, i.e. CCR6 (CD196),
IL-23R, IL-12Rbeta2 and CD161.
Aim of the study
Was to estimate the proportions of circulating CD4+
CD161+CD196+ and CD4+IL-17+ Th17 cells and serum
concentrations of IL-17 & IL-23 in patients with Graves’
disease (GD, n=22, mean age ± SEM 14.3 ± 4 years), Hashi-
moto’s thyroiditis (HT, n=37, mean age ± SEM 15 ± 2 yrs)
and in healthy controls (C, n=25, mean age ± SEM 15.2 ± 2
yrs).
Material and methods
Polychromatic flow cytometry and several fluorochrome-
conjugated monoclonal antibodies were applied to deline-
ate Th17 cells with either CD4+CD161+CD196+ or CD4+
IL-17+ phenotype using apparatus FACSCalibur (BD Bios-
ciences). The expression of IL-17 and IL-23 were analyzed
by Bio-Tek ELx800 ELISA reader. Thyroid anti-TSH
receptor immunoglobulins (TRAK), anti-thyroperoxidase
(anti-TPO) and anti-thyroglobulin (anti-TG) antibodies
were measured in all the samples using electrochemilumi-
nescence “ECLIA” with Modular Analytics E170 analyzer
(Roche Diagnostics, Poland).
Results
In untreated HT children we observed an increased per-
centage of CD4+CD161+CD196+ (7.1±3.5 vs. 3.7±1.8;
p<0.04) and CD4+IL-17+ (3.7±2.7 vs. 1.4±0.4; p <0.01)
Th17 lymphocytes in comparison to the healthy controls.
In GD children we did not reveal such abnormalities in
the population of these cells. In cases with HT, a positive
correlation between the percentage of CD4+IL-17+ and
CD4+CD161+CD196+ T cells and serum level of anti-
TPO antibodies (r=0.48; p<0.025; r=0.65; p<0.01; respec-
tively) was detected. In untreated patients with AITD we
observed an increased levels of IL-23 in comparison to
control group (GD:156.29±118.22 vs. 69.04±38.23,
p=0.004, HT:135.04±140.19 vs. 69.04±38.23, p=0.046).
Methimazole treatment in GD led to decrease of these
cytokine levels in a period of 6-12 months. However, dur-
ing 6-24 months of L-thyroxine therapy in HT there
wasn’t any reduction of IL-23 concentration compared
with HC. IL-17 was elevated only in HT patients in com-
parison to the controls (17.17±10.49 vs. 11.38±2.99,
p=0.021), which normalized during therapy.
Conclusions
We conclude that the increased percentage of Th17
cells and elevated level of IL-17 and IL-23 cytokines in
children with HT can suggest their role in initiation and
development of immune and inflammatory processes in
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